SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: TideGlider who wrote (138)11/19/1997 7:03:00 PM
From: Bob Swift  Read Replies (2) | Respond to of 656
 
>>If this stock heads down and breaks 60 their will be no cushion. It will free fall to the 42 levcel...then the next strength seems to be 36...29 and 20....<<

Exactly what I fear too. The upside from here is too limited. Not too many positive news will surface between now and 1998 when the FDA filing takes place. The downside is hugh. The risk outweight the reward quite a bit.
I watched IMNX tick by tick today and get more worried. Most of the trades are 100 shares or so. This so-called rebound happened on light volume looks dangerous to me.



To: TideGlider who wrote (138)11/21/1997 8:17:00 PM
From: Howard Henick  Respond to of 656
 
calm down. the nationbank guy is a nobody trying to make a name for himself. the guy at dlj says 120is the target and AHP didn't give these guys 100mm because enbrels a flop. dlj will ultimately be right. this is a 100 plusw dollar stock. relax!!